2011
DOI: 10.1038/ejhg.2011.166
|View full text |Cite
|
Sign up to set email alerts
|

Beckwith–Wiedemann syndrome caused by maternally inherited mutation of an OCT-binding motif in the IGF2/H19-imprinting control region, ICR1

Abstract: The imprinted expression of the IGF2 and H19 genes is controlled by the imprinting control region 1 (ICR1) located at chromosome 11p15.5. DNA methylation defects involving ICR1 result in two growth disorders with opposite phenotypes: an overgrowth disorder, the Beckwith-Wiedemann syndrome (maternal ICR1 hypermethylation in 10% of BWS cases) and a growth retardation disorder, the Silver-Russell syndrome (paternal ICR1 loss of methylation in 60% of SRS cases). In familial BWS, hypermethylation of ICR1 has been f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
52
0
2

Year Published

2012
2012
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 61 publications
(58 citation statements)
references
References 10 publications
4
52
0
2
Order By: Relevance
“…It was reported that dyad Oct-binding sequences located in the ICR21 region mediated the maintenance of DNA hypomethylation at the H19 ICR in cultured cells (44,45). Curiously, the binding sequences are conserved in humans and were found to be mutated in Beckwith-Wiedemann syndrome (BWS) patients with ICR gain-of-methylation phenotypes, even though they have intact CTCF sites (46,47). Therefore, the binding of CTCF as well as other factors, including Oct proteins, to the maternal H19 ICR may be required to fully protect its CpG sites from de novo DNA methylation.…”
Section: Discussionmentioning
confidence: 99%
“…It was reported that dyad Oct-binding sequences located in the ICR21 region mediated the maintenance of DNA hypomethylation at the H19 ICR in cultured cells (44,45). Curiously, the binding sequences are conserved in humans and were found to be mutated in Beckwith-Wiedemann syndrome (BWS) patients with ICR gain-of-methylation phenotypes, even though they have intact CTCF sites (46,47). Therefore, the binding of CTCF as well as other factors, including Oct proteins, to the maternal H19 ICR may be required to fully protect its CpG sites from de novo DNA methylation.…”
Section: Discussionmentioning
confidence: 99%
“…However, singlenucleotide mutations were shown to prevent binding of pluripotency factors (OCT4 and SOX2) to the H19 ICR. Interestingly, these mutations induced aberrant acquisition of DNA methylation at this ICR and biallelic expression of the locus' IGF2 gene, resulting in an overgrowth upon maternal, but not upon paternal, transmission (Demars et al, 2010;Poole et al, 2012). Mouse studies have shown that Igf2 overexpression induces fetal and postnatal overgrowth, and Peg1 overexpression leads to reduced growth and fat mass expansion.…”
Section: Genetic Polymorphisms and The Control Of Mono-allelic Gene Ementioning
confidence: 99%
“…However, data for adult height are inconclusive because of lack of information due to the discontinuation of follow-up after the usual period of surveillance for the occurrence of tumors. Several studies have reported patients in small cohorts to have a final height in the normal range [8,9,10,11], whereas others have reported adult heights exceeding +2 SDS [12,13,14,15,16,17,18] (table 1). …”
Section: Introductionmentioning
confidence: 99%